NATCO Pharma
This idea is only for educational purposes
Turnaround is happening in the company ( Added fundamental and technical ).
i) Recently company received approval for the cancer medicine
ii) Latest quarter's profit increased 5 times the previous quarter
iii) Promoter, FII, and DII increased the stock holding
iv) Technical points
a) Above 3o weeks ema
b) RS is positive
c) today broke the consolidation zone with a high volume
d) making HH and HL
Note:
Turnaround is happening in the company ( Added fundamental and technical ).
i) Recently company received approval for the cancer medicine
ii) Latest quarter's profit increased 5 times the previous quarter
iii) Promoter, FII, and DII increased the stock holding
iv) Technical points
a) Above 3o weeks ema
b) RS is positive
c) today broke the consolidation zone with a high volume
d) making HH and HL
Note:
- 1st target 750 short-term duration
- Long term 900 plus ( based on next quarter's result)
- 1st target 750 short-term duration
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.